Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
Management of NSCLC with resistance to first line targeted therapy
- Type: Educational session
- Presentations: 5
- Moderators:L. Horn
- Coordinates: 5/07/2017, 09:00 - 10:30, Room B
-
+
Management of T790M positive disease after EGFR TKI failure
09:00 - 09:20 | Author(s): L. Horn
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Management of T790M negative disease after EGFR TKI failure
09:20 - 09:40 | Author(s): M. Krebs
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Management of drug resistance in ALK positive NSCLC
09:40 - 10:00 | Author(s): D.S. Tan
- Abstract
No abstract available for this presentation
-
+
Management of resistance in other targets beyond ALK and EGFR
10:00 - 10:20 | Author(s): L. Friboulet
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Questions and Answers
10:20 - 10:30
- Abstract
No abstract available for this presentation
-
+
Poster Display Session
- Type: Poster Display Session
- Presentations: 142
- Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
-
+
131P - T790M co-exists with other secondary resistance mechanisms in EGFR mutation positive NSCLC and are associated with inferior outcomes
12:30 - 12:30 | Author(s): R. Teng
- Abstract
Loading...